Oncology & Cancer

Discovery could lead to better cancer immunotherapy

A type of white blood cell previously known only as a helper in the immune system appears also to be the instigator of the body's defenses against cancerous tumors. The discovery could lead to more effective cancer immunotherapy, ...

Oncology & Cancer

Recent diabetes and weight loss tied to pancreatic cancer risk

(HealthDay)—Recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer, according to a study published online Aug. 13 in JAMA Oncology.

Oncology & Cancer

Sulfur microbial diet may increase risk for colorectal cancer

(HealthDay)—Greater adherence to a sulfur microbial diet is associated with an increased risk for colorectal cancer (CRC) in both men and women, according to a study published online Nov. 12 in JAMA Network Open.

Medications

Aspirin could increase survival in cancer

Does aspirin increase survival in cancer patients? UK researchers say that despite the smaller side-effects of aspirin, taking the drug has an overall positive effect on survival for people with cancer. The team reviewed ...

Oncology & Cancer

CD40 combination therapy can shrink pancreatic tumors

A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients—20 out of 24 as of an interim analysis of the phase 1b trial data. The early findings ...

Oncology & Cancer

Link for asbestos-free talcum powder, cancer not clear

(HealthDay)—Talcum powder, made from talc, which contains asbestos is considered carcinogenic to humans, while the carcinogenicity of talc without asbestos is unclear, according to the American Cancer Society.

page 12 from 40